Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
-0.66%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 07 February 2024 10:24 pm  |  Updated:  Thursday 07 March 2024 4:30 pm

Arm: AI boom “is real” as New York-listed Cambridge firm soars

By: Andy Silvester

Add as a preferred source on Google
Applied Materials shares surge 12% on bullish revenue forecast amid AI craze
Applied Materials shares surge 12% on bullish revenue forecast amid AI craze

Arm, the UK chipmaker which listed in New York, proved the worth of its fundamentals on Wednesday evening – beating analyst estimates and sending shares soaring.

Demand for artificial intelligence upgrades has boomed across the global economy and Arm has benefitted, bosses said.

“We’re seeing more interest in newer designs and newer technologies by customers” Jason Child, Arm’s chief financial officer, told Reuters.

“It’s real. Folks are actually buying and licensing that technology.”

Arm floated in New York last year after an arm wrestle between NASDAQ and the London Stock Exchange, which the capital’s flagship bourse lost.

Arm reported sales north of $800m in the third quarter, way ahead of analysts’ consensus at $761m.

Shares rocketed almost 30 per cent in after hours trading.

Read more

Arm Announces Earnings Release Date for First Quarter Fiscal Year Ended 2027

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • ARM Holdings

Trending Articles

  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

  • Analysis: What would Todd Boehly and Mark Walter stake sales mean for Chelsea?

  • We take a food and drink Odyssey through the Square Mile

  • Paramount-Warner Bros deal faces ‘sufficient competition’, says CMA

  • Watchdog takes aim at lawyers blaming juniors for AI blunders

More from Morning Wire

  • Arm Announces Earnings Release Date for First Quarter Fiscal Year Ended 2027

    Business Wire
  • Arm Holdings plc Reports Results for the First Quarter of the Fiscal Year Ending 2027

    Business Wire
  • Sky buys ITV broadcasting arm in £1.6bn deal

    Media
    Studios revenue rose three per cent to £893m, driven by an 11 per cent jump in external sales to streaming platforms.
  • City trading ‘higher than thought’, FCA believes

    Markets
    GettyImages 2211256637 showing a significant event or figure relevant to recent news updates in the business sector
  • HSBC sells Singapore insurance arm to Allianz in £1.6bn deal

    Banking
    HSBC's stock has taken a hit due to the huge tariffs slapped on Asian countries.
  • Point2 Completes $136M Series B Funding with Arm, LB Investment, and Maverick Silicon

    Business Wire
  • BP eyes finalising sale of solar arm to Kuwait-backed wealth fund

    Energy
    British Petroleum BP forecourt with fuel pumps and company signage visible in a business setting, highlighting energy serv...
  • Unilever turns to ‘avocado mayonnaise’ as food weighs on profit ahead of spin-off

    Retail
    Hellmanns Real Mayonnaise jar in a refrigerator with fresh vegetables like tomatoes, lettuce, and onions
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook